痛风石手术治疗的术后并发症与结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入18项回顾性研究,评估痛风石手术治疗的术后并发症与复发负担;合并术后感染率为11.3%(95%CI 8.0%-15.7%),延迟愈合9.9%(95%CI 5.1%-18.2%),复发8.5%(95%CI 4.7%-14.9%),总体并发症24.0%(95%CI 14.0%-38.1%),证据确定性均为极低。
要点
- 痛风石术后合并感染率11.3%、总体并发症24.0%,围手术期风险需重视。
- 复发率8.5%、再手术率9.7%、截肢率3.7%,需长期降尿酸管理配合。
- 仅感染在解剖部位与干预类型间存在亚组差异,全部结局证据确定性极低。
核心结论
- 痛风石手术治疗存在可测量的术后风险,尤其是感染与总体并发症。
- 结果支持细致的围手术期咨询、结构化的术后监测与整合的长期降尿酸管理。
研究设计与样本
- 系统检索PubMed、Embase、Web of Science与Cochrane Library,检索时间自建库至2026年3月25日。
- 纳入报告痛风石手术术后结局的原创研究,共18项回顾性研究,采用随机效应单臂荟萃分析合并事件率。
主要发现
- 合并术后感染率为11.3%(95%CI 8.0%-15.7%)。
- 延迟伤口愈合率为9.9%(95%CI 5.1%-18.2%),复发率为8.5%(95%CI 4.7%-14.9%)。
- 再手术率为9.7%(95%CI 5.5%-16.7%),截肢率为3.7%(95%CI 2.0%-6.8%),总体并发症率为24.0%(95%CI 14.0%-38.1%)。
- 仅感染在解剖部位与干预类型间发现显著亚组差异,敏感性分析显示合并估计稳健,所有结局证据确定性均为极低。
关键数值与推荐
- 主要结局为术后感染、延迟伤口愈合与复发;次要结局为再手术、截肢与总体并发症。
- 功能结局仅作描述性总结。
临床怎么用
- 术前应就感染、延迟愈合、复发、再手术与截肢风险进行充分沟通。
- 术后应建立结构化监测,并整合长期降尿酸治疗以降低复发负担。
局限性
- 纳入研究均为回顾性研究,所有结局的证据确定性均为极低。
- 功能结局仅作描述性总结,未来研究需标准化报告围手术期危险因素与术后结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical treatment remains necessary for selected patients with tophaceous gout, particularly when mechanical limitation, nerve compression, ulceration, infection, deformity, or failure of conservative treatment is present. However, postoperative outcomes after surgery for tophaceous gout have not been comprehensively quantified. This systematic review and meta-analysis evaluated postoperative complication profiles and recurrence burden after surgical treatment for tophaceous gout. METHODS: A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted from database inception to March 25, 2026. Original studies reporting postoperative outcomes after surgical treatment for tophaceous gout were included. Pooled event rates with 95% confidence intervals (CIs) were calculated using a random-effects single-arm meta-analytic approach. Primary outcomes were postoperative infection, delayed wound healing, and recurrence. Secondary outcomes were reoperation, amputation, and overall complications. Functional outcomes were summarized descriptively. RESULTS: 18 retrospective studies were included. The pooled postoperative infection rate was 11.3% (95% CI 8.0%-15.7%), delayed wound healing 9.9% (95% CI 5.1%-18.2%), and recurrence 8.5% (95% CI 4.7%-14.9%). Secondary pooled rates were 9.7% (95% CI 5.5%-16.7%) for reoperation, 3.7% (95% CI 2.0%-6.8%) for amputation, and 24.0% (95% CI 14.0%-38.1%) for overall complications. Significant subgroup differences were identified only for infection according to anatomic site and intervention type. Sensitivity analyses showed that pooled estimates were robust. The certainty of evidence was very low for all outcomes. CONCLUSIONS: Surgical treatment for tophaceous gout is associated with measurable postoperative risks, particularly infection and overall complications. These findings support careful perioperative counseling, structured postoperative surveillance, integrated long-term urate-lowering management, and more standardized reporting of perioperative risk factors and postoperative outcomes in future surgical studies of tophaceous gout.
引用
- Xie RZ, Li XS, Wu WR, et al. Postoperative complications and outcomes after surgical treatment for tophaceous gout: A systematic review and meta-analysis. Semin Arthritis Rheum. 2026. PMID: 42398310. doi:10.1016/j.semarthrit.2026.153038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。